A case study of the utilization of clozapine treatment for treatment-resistant schizophrenia associated with 22q11.2 deletion syndrome.
Arisa TsurueHideki FunahashiKeiichi TsurueMasahiko KawanoYasushi IshidaYoji HiranoPublished in: Neuropsychopharmacology reports (2023)
Clozapine may serve as an efficacious pharmacological intervention for TRS patients with 22q11.2DS, including those of Asian descent.